GenVec’s cattle vaccine gets conditional approval, shares up

(Reuters) – GenVec Inc said its foot and mouth disease (FMD) vaccine got a conditional approval from a U.S. regulator, sending its shares up 17 percent. The vaccine is GenVec’s first approved product. The company said the Animal and Plant Health Inspection Service (APHIS) under the U.S. Department of Agriculture (USDA)issued a conditional license to Antelope Valley Bios Inc, which manufactures the vaccine under a contract from GenVec. Foot-and-mouth disease is a severe, highly contagious viral disease of cloven-hooved animals, although not usually fatal. …